Guardant Health, Inc. (GH): Revenue
$982.02M
Year ended 2025-12-31
$1.18B
Trailing 12 months to 2026-06-30
+29.8%
3-year compound annual growth
+27.9%
5-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $982.02M | +32.9% | 2026-02-19, From 2025-01-01 |
| 2024-12-31 | $739.02M | +31.0% | 2026-02-19, From 2024-01-01 |
| 2023-12-31 | $563.95M | +25.5% | 2026-02-19, From 2023-01-01 |
| 2022-12-31 | $449.54M | +20.3% | 2025-02-20, From 2022-01-01 |
| 2021-12-31 | $373.65M | +30.3% | 2024-02-22, From 2021-01-01 |
| 2020-12-31 | $286.73M | +33.8% | 2023-02-23, From 2020-01-01 |
| 2019-12-31 | $214.38M | +136.5% | 2022-02-24, From 2019-01-01 |
| 2018-12-31 | $90.64M | +81.9% | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | $49.84M | +97.4% | 2020-03-02, From 2017-01-01 |
| 2016-12-31 | $25.25M | n/a | 2019-03-19, From 2016-01-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| Guardant Health, Inc. (GH) | 2025-12-31 | $982.02M | +32.9% |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | $812.03M | +97.0% |
| Veracyte, Inc. (VCYT) | 2025-12-31 | $517.14M | +16.0% |
| RadNet, Inc. (RDNT) | 2025-12-31 | $2.04B | +11.5% |
| Natera, Inc. (NTRA) | 2025-12-31 | $2.31B | +35.9% |
| CareDx, Inc. (CDNA) | 2025-12-31 | $379.81M | +13.8% |
| Fortrea Holdings Inc. (FTRE) | 2025-12-31 | $2.72B | +1.0% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $344.23M | +3.7% |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | $322.67M | +13.8% |
Compare GH, CAI, VCYT, RDNT side by side · Screen every company in Services-Medical Laboratories ↗